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Abstract 
 
 
 ZFPIP (Zinc Finger Pbx1 Interacting Protein) has been recently identified in our 
laboratory in a yeast two hybrid screen using an embryonic mouse cDNA library and PBX1 as 
a bait. This gene encodes a large protein (250 kDa) that contains a bipartite NLS, numerous 
C2H2 zinc fingers and is highly conserved amongst vertebrates. In order to address the role of 
ZFPIP during embryonic development, we analysed the expression pattern of the gene and 
performed morpholinos injections into Xenopus laevis embryos. We first showed that the 
ZFPIP protein was maternally present in oocytes. Then, ZFPIP was detected from morula to 
neurula stages in the nucleus of the cells, with a gradient from animal to vegetal pole. By 
injection of ZFPIP morpholinos, we showed that morphant embryos were unable to undergo 
proper gastrulation and subsequently exhibited a persistent opened blastopore. Analysis of 
molecular and cellular events that were altered in morphant embryos highlighted an 
impairment of cell division processes as illustrated by atypical mitosis with aberrant 
metaphase, anaphase or telophase, incomplete chromosome segregation or conjointed nuclei. 
The overall data presented here demonstrated that ZFPIP was a major developing gene that 
acts in the very first steps of embryonic development of Xenopus laevis.  
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Introduction 
 
 Homeodomain proteins play crucial roles in the developmental processes of many 
multicellular organisms. As transcription factors, they contribute with specific partners to 
modulate several genetic programs throughout organism life. Amongst homeodomain 
proteins, PBX1 is essential for the development of most area of the embryo. PBX1 was 
initially identified as a proto-oncogene in human leukaemia induced by the expression of the 
oncogenic fusion E2a-PBX1 protein (Kamps et al., 1990; Nourse et al., 1990). PBX1 belongs 
to the TALE family of proteins characterized by a Three Amino Acids Loop Extension within 
their homeodomain. Demonstration was made that PBX proteins were able to interact with a 
subset of HOX proteins and as such were considered as essential HOX cofactors involved in 
developmental gene regulation (Moens and Selleri, 2006). However, increasing amount of 
data revealed that PBX1 can act as cofactor of other non homeodomain containing 
developmental regulators (Laurent et al., 2008). We have recently identified a new PBX1 
interacting factor that we named ZFPIP for Zinc Finger PBX1 Interacting Protein (Laurent et 
al., 2007). This factor corresponds to a large protein of 250 kDa containing several zinc 
fingers that is expressed mainly in the forebrain, midbrain and the limb buds of mouse 
embryo. The ZFPIP cDNA was also isolated by a microarray-based approach aiming to 
identify genes involved in the process of cortical arealization and the gene has been referred 
to as Zfp462 (Chang et al., 2007). In order to gain insights into the role of this gene during 
vertebrate development, we used the Xenopus laevis model. Indeed, the xenopus embryo is 
well suited for investigations of developmental and cellular processes because of its well 
characterized invariant cell fate map and the ability to assess the functional effects of proteins 
on developmental pathways. Surprisingly, we observed that the ZFPIP/Zfp462 protein was 
present in xenopus egg, a stage at which no PBX1 expression is detected (Maeda et al., 2002). 
These data suggested that ZFPIP/Zfp462 is involved in non-PBX1 dependant mechanisms 
which might be crucial for early xenopus development. Using a morpholinos based strategy, 
we showed that knock-down expression of ZFPIP/Zfp462 impaired very early development of 
xenopus. Indeed, during the cleavage phase, cells under-expressing ZFPIP/Zfp462 exhibited 
altered cell division, resulting in aberrant DNA repartition in daughter cells. These altered 
processes led to defects in the subsequent gastrulation of the embryos. We thus have 
identified a new developmental gene which is instrumental as maternal factor during cleavage 
phase of xenopus development. 
 
 
 
 
Materials and methods 
 
Materials  
 
 Specific ZFPIP and control Morpholinos were purchased from Gene-tools (Gene-
tools, Inc). Two different antisense Morpholino oligonucleotides against xZFPIP mRNA were 
designed as follows:  
MO1 xZFPIP: 5’GACUUCCAUAUUCCUAAACCAGG 3’ 
MO2 xZFPIP: 5’TTCCTAAACCAGGATTTTCATTAGG 3’ 
 Two different controls were used in the experiments: the sequence of the standard 
Control Morpholino oligonucleotide (ctrl MO) provided by Gene-tools and a Morpholino 
oligonucleotide corresponding to the MO1 sequence except for 5 bases (ctrl MO1). The 
sequences of these 2 Morpholinos were designed as follows: 
Ctrl MO: 5’CCTCTTACCTCAGTTACAATTTATA 3’ 
Ctrl MO1: 5’GAgUUCgAUAUUgCUAAAgCAcG 3’ 
 The cDNA encoding GFP, hZFPIP, hZFPIP-FLAG were inserted into the pT7TS 
vector (generous gift from Jean-Pierre Tassan, IGDR France). The resulting vectors were 
linearized and in vitro transcription assays were performed using mMessage mMachine kit 
according to manufacturer’s protocol (Ambion). 
 
 
Sequence analysis 
 
 The data base search was performed using the BLAST (Basic Local Alignment Search 
Tool) program (Altschul et al., 1997). The alignments were obtained using the MultiAlin 
program (Multiple sequence Alignment, INRA, Institut National de Recherche Agronomique, 
Toulouse, France) (Corpet, 1988). 
 
 
Embryos manipulations 
 
 Xenopus laevis embryos were obtained by in vitro fertilization after stimulation of 
female with 500 i.u. of human chorionic gonadotropin hormon.  
 Morpholinos (ctrl MO, ctrl MO1, xZFPIP MO1 and xZFPIP MO2) and RNAs 
(hZFPIP mRNA, hZFPIP-FLAG mRNA, GFP mRNA) were injected in one or two 
blastomeres of two-cell stage embryos. GFP mRNAs were co-injected as a lineage tracer. 
Amounts injected ranged from 25 to 50 ng of morpholinos or 1 to 5 ng of RNAs in a maximal 
volume of 9.2 nL. Injected or not injected embryos were allowed to develop at 16°C and were 
regularly observed. For whole mount immunohistochemistry and TUNEL assays, embryos 
were fixed in MEMFA buffer (0.1M MOPS pH 7.4; 2mM EGTA; 1mM MgSO4; 3.7% 
formaldehyde) or stored at -80°C for RNA extraction. Studies were performed at several 
stages according to the table of Nieuwkoop and Faber (1994). 
 
 
RNA extractions and quantitative RT-PCR 
 
 Total RNAs were extracted from whole embryos using Nucleospin kit (Macherey-
Nagel). One microgram of total RNA from each time point was reverse transcribed to cDNA 
using random primer hexamers (New England Biolabs). For RT-PCR experiments (Xbra, 
Sox17α and Sox2), PCR conditions were 94°C for 45 s, annealing for 45 s at 50°C during 25 
cycles. PCR reactions were completed by a final extension at 72°C for 10 minutes. For 
quantitative Real-Time PCR, primers were designed with Primer ExpressTM software 
(Applied Biosystems). Samples along with primers and Syber Green Master Mix (Applied 
Biosystems) were run in an ABI Prism 7000 SDS (Applied Biosystems) according to the 
manufacturer’s protocol. Relative quantification of ZFPIP mRNA in each sample was 
calculated by comparison of their Ct values previously normalized with Ct values obtained for 
ODC (Ornithine Decarboxylase) internal control amplification. Experiments were run three 
times from different RNA extractions. The standard deviations reflect variability within 
triplicates. Primers used in Real-Time PCR experiments were designed as follows:  
ODC-F: 5’AAAATGGATGACTGCGAGATGGG 3’ 
ODC-R: 5’AATGAAGATGCTGACTGGCAAAAC 3’;  
xZFPIP-F: 5’GCAGCAGATTGGTAATGATTGAGT 3’  
xZFPIP-R: 5’AAACTACAAGGATGGGCAAGGA 3’ 
Xbra-F: 5’TGGCACCAGAGAATGATCAC 3’ 
Xbra-R: 5’TGCGGTCACTGCTATGAACTG 3’ 
Sox17α-F: 5’TACTGCAACTACCCCAGTGC 3’ 
Sox17α-R: 5’AGAGCCCGTCCTTCTCAATA 3’ 
Sox2-F: 5’CTCTGCACATGAAGGAGCAT 3’ 
Sox2-R: 5’CCCGGGCAGAGTGTACTTAT 3’ 
 
 
Protein extracts and Western blot analysis 
 
 Oocytes were treated or not with 10 µg/ml cycloheximide and collected at different 
times. Embryos or oocytes were disrupted and homogenized in lysis buffer (10 mM Hepes pH 
7.5; 0.25 mM KCl; 0.25 M Sucrose; 10 % Glycerol; 0.2 mM EDTA; 0.15 mM EGTA) 
containing a mix of proteases inhibitors (Sigma). The proteins were then Freon extracted, 
separated on SDS–polyacrylamide gel and electro-transferred onto PVDF membrane 
(Immobilon). Western blots were performed using an anti-PCNA (α-PCNA) antibody 
(Sigma) and with an anti-ZFPIP serum (α-ZFPIP; (Laurent et al., 2007)). 
 
 
Whole mount expression analysis 
 
 For whole-mount immunohistochemistry, wild type embryos were depigmented in 
hydrogen peroxide and permeabilized in PBS + 0.5 % Triton X-100. After blocking in PBS + 
10 % Goat serum + 10 % BSA, they were incubated with α-ZFPIP immune serum or with 
preimmune serum control overnight at 4°C. The secondary antibody used was HRP- or 
AP-conjugated and staining was performed with Diaminobenzidine or BM-purple (Roche).  
  
 
Microscopy 
 
 For fluorescence microscopy, explants were dissected from fixed stage 12 embryos 
injected with hZFPIP-FLAG mRNA, xZFPIP MO1, xZFPIP MO2, ctrl MO or ctrl MO1. 
Immunostaining was carried out using either an anti-FLAG antibody (α-FLAG, Sigma) or an 
anti-phosphohistone H3 antibody (α-PH3, Upstate Biotechnology, 1:1000). Fluorochrome-
conjugated goat anti-rabbit IgG (Alexa Fluor® 555 goat anti-rabbit IgG, Invitrogen, 1:1000) 
was used as a secondary antibody. F-actin staining was obtained with Phalloidin-Fluoroprobe 
547H procedure (Interchim). Nuclei staining was obtained with 0.5 µg/mL DAPI. Samples 
were viewed with a fluorescence microscope
 
(DMRXA; Leica) with a 40x NA 1.32 lens 
equipped with standard
 
fluorescence filters or a confocal Leica TCS SP2 microscope. 
Confocal images were processed using LCS LEICA confocal softwares. 
 
 
Whole mount t unnel assay 
 
 Injected Xenopus albino embryos were collected when controls reached stage 20-22 
and processed for TUNEL (TdT-mediated dUTP-X nick end labelling) assays using a 
protocol adapted from Hensey and Gautier (1999). Following removal of the vitelline 
membrane in PBS, embryos were sequentially washed in PBS + 0.2% Tween 20 and TdT 
buffer (Invitrogen). End labeling of breaks in DNA was carried out overnight at room 
temperature in TdT buffer containing 150 U/µl terminal deoxynucleotidyl transferase (TdT, 
Invitrogen) and 0.5 µM digoxygenin-dUTP (Roche diagnostics). Embryos were then washed 
in PBS + 1mM EDTA (2 x 1h, at 65°C) and PBS (4 x 1h). After blocking in PBS containing 
0.1 % Triton X-100 + 2 mg/ml BSA + 20 % goat serum for 1h, embryos were incubated 
overnight at 4°C with alkaline phosphatase-conjugated anti-digoxygenin Fab fragments 
(1/2000; Roche diagnostics). Following multiple washes in PBS + 0.1 % Triton X-100, the 
chromogenic reaction was performed in NBT/BCIP solution (Interchim). When reactions 
reached the desired intensity, embryos were transferred to MEMFA for 3h and stored in 
methanol. 
 
 
Results and discussion 
 
ZFPIP/Zfp462 is a large protein containing multiple Zinc Finger motifs  
 
 Data bases searches revealed that the mouse ZFPIP/Zfp462 cDNA encodes a protein 
that is highly conserved between vertebrates (figure 1A, B). As previously mentioned 
(Laurent et al., 2007), the protein contains 34 zinc finger motifs amongst which 26 are 
conserved from zebrafish to Human (figure 1A). Furthermore, three of these zinc finger 
modules constitute a triplet at the C-terminus end of the protein that is close but not identical 
to the DNA binding domain found in Krüppel like factors. The presence of numerous zinc 
finger motifs within a large protein (250 kDa) suggests that this protein could play multiple 
roles such as DNA/RNA binding factor or partner of several different proteins. In addition, 
the protein contains at least one bipartite NLS which is sufficient to target the protein to the 
nucleus (Laurent et al., 2007).  
 In order to reconstitute the xenopus ZFPIP cDNA, we first used Xenopus laevis and 
Xenopus tropicalis ESTs available in data bases. Since parts of the cDNAs were missing in 
the two species, we performed partial cDNAs sequencing of the Xenopus laevis cDNA and we 
were able to get an hybrid xenopus cDNA. By comparing the overlapping sequences of 
Xenopus laevis and tropicalis cDNAs, the corresponding proteins were predicted to be at least 
94% homologous (figure 1C). 
 
 
Expression pattern of ZFPIP in Xenopus laevis embryos  
 
 Real-Time Reverse-Transcription PCR assays indicated that the amount of ZFPIP 
transcripts was quite stable in whole embryo from fertilization (stage 1) to early gastrulation 
stage (stage 11). This amount then decreased slightly at stage 12. Compared to this stage, the 
level of ZFPIP mRNAs exhibited a 4 fold increase at stage 36. These data indicated that 
ZFPIP mRNAs were maternally stored in xenopus oocyte and then degraded. After MBT, 
these RNAs are zygotically transcribed and we observed a significant increase of the mRNAs 
level at stage 17 when neurulation occurs. This level of ZFPIP mRNAs was maintained until 
stage 36 (figure 2A). 
 Western blots analysis revealed that the ZFPIP protein was also maternally stored in 
oocyte, since ZFPIP was detected as early as stage VI postvitellogenic oocytes and was 
abundant at stage 1. After stage 7, the relative amount of the protein was then lower in the 
embryo from stage 10 to stage 33. A slight increase was then observed after stage 33 (figure 
2B). By dissecting the animal and vegetative poles (stage 9), we observed that the protein was 
essentially localised at the animal pole of the embryos (figure 2D). 
 In order to complete this expression pattern, we performed whole-mount 
immunochemistry using a specific ZFPIP antibody (figure 2C). We confirmed that at the 
morula and blastula stages, the protein preferentially localised at the animal pole of the 
embryo. Later in the neurula stage, ZFPIP seemed to be present in the neural folds, neural 
plate, neural crest and presumptive eyes region. This preferential expression in nervous and 
sensory region was more evident in tail bud stage, where ZFPIP was detected in the head 
including otic vesicules and eyes, cardiac region, spinal cord and somites. This regionalization 
of ZFPIP during neurulation explains the decreasing amount of the protein observed in 
Western blot.  
 In addition, the immunostaining of the endogenous protein observed in stages 8 (not 
shown) and 20 embryos was clearly nuclear (figure 2E). This nuclear localization was 
confirmed by an additional experiment that has consisted in over-expressing an hZFPIP-
FLAG protein into xenopus embryos and that has shown an immunostaining in the nucleus of 
embryo cells (figure 2E).   
 The particular pattern of expression of ZFPIP suggested the involvement of the protein 
at two crucial moments during xenopus development. Firstly, the high amount of maternally 
stored protein indicated that it could play a key role during the cleavage phase. Indeed, 
considering the structure of ZFPIP with several zinc finger motifs, it likely interacts with 
DNA, RNA and different proteins and could therefore participate in multiple fundamental 
processes during pre-MBT xenopus development such as RNA stability, DNA conformation, 
replication, transcription inhibition or chromosome segregation. Secondly, the regionalization 
of the protein observed during neurulation might indicate its involvement in neural cell 
differentiation process. Accordingly, previous studies have demonstrated that ZFPIP is mostly 
present in the central and peripheral nervous system of the mouse embryo (Laurent et al., 
2007; Chang et al., 2007). In addition, our previous work had indicated that ZFPIP interacts 
with PBX1 (Laurent et al., 2007) but also with some HOX proteins (data not shown). This 
ability to strongly interact with PBX1 and HOX proteins indicates that ZFPIP might be a 
more general partner of homeodomain proteins and might be involved in several 
developmental processes. In order to explore the role of this gene, we undertook an 
experiment aiming to knock-down its expression in vertebrate embryo. 
 
 
ZFPIP morpholinos disrupt  Xenopus laevis early development 
 
 Since the ZFPIP protein was already present at stage 1 of xenopus development, it was 
necessary to evaluate the turn over of the protein before starting the knock-down of the gene 
by a morpholinos strategy. Indeed, a high stability of the protein could have rendered 
inefficient this approach. We thus estimated the turn over of the protein by incubating stage 
VI oocytes in cycloheximide and observed that the ZFPIP protein began to be degraded after 
24 hours of treatment and was fully degraded at 84 hours (figure 3A). This relative instability 
of the protein in oocytes suggested that the morpholinos strategy was relevant to knock-down 
the expression of the gene in the embryo. We thus started a series of experiments aiming to 
knock-down the gene by a morpholinos strategy. For this purpose, we used two different 
specific morpholinos (MO1 and MO2, see methods for the design) and two different controls 
(ctrl MO and ctrl MO1, see methods for the design). Most of the data presented in figures 4 to 
6 are those obtained with xZFPIP MO1 but identical results were obtained with xZFPIP MO2.  
 The first experiment has consisted in injecting specific xenopus ZFPIP morpholinos 
(xZFPIP MO1) in stage VI oocytes. Following morpholinos injection, we observed the 
complete disappearance of the ZFPIP protein within 48 hours (figure 3B) whereas no 
variation of the protein was observed in oocytes injected with control morpholinos (ctrl MO). 
Considering that the stability of ZFPIP was compatible with a morpholinos strategy and since 
the designed xZFPIP morpholinos were efficiently targeting the ZFPIP mRNA, we performed 
the knock-down of the gene in xenopus embryo. We performed the injection of ZFPIP 
morpholinos in one blastomere at two-cell stage and compared the development of one 
blastomere versus the other. Injection of these specific morpholinos of xZFPIP mRNAs 
(xZFPIP MO1) caused abnormal gastrulation and failure of blastopore closure in at least 54% 
of the embryos (figure 3C-D, figure 4). This abnormal development of the injected part of the 
embryo was correlated to a significant decrease of ZFPIP protein as shown by Western blot in 
figure 3E. Injection of xZFPIP MO1 in the two blastomeres of the embryo was also 
performed and led to a high percentage of mortality (data not shown). The experiment was 
reproduced using another specific xZFPIP morpholinos, designated as xZFPIP MO2. The 
same phenotype was observed in xZFPIP MO2 morphants than in xZFPIP MO1 injected 
embryos with 90% of the embryos showing abnormal phenotype. This abnormal development 
was correlated to the nearly depletion of ZFPIP protein as shown by Western blot (figure 3E). 
 In order to ensure that the phenotype observed was linked to the absence of ZFPIP 
protein, we attempted to rescue the effects of the xZFPIP MOs by coinjection of the human 
ZFPIP mRNA (hZFPIP mRNA) which is not targeted by xZFPIP MOs. As illustrated in 
figure 4, coinjection of xZFPIP MO1 with hZFPIP mRNA restored a normal phenotype for 
70 % of the embryos. Interestingly, over-expression of hZFPIP RNA did not induce any 
particular phenotype.   
 The data presented above clearly demonstrated that ZFPIP was essential for proper 
early stages of xenopus embryogenesis. The crucial role of this gene in development has been 
noticed by others. Indeed, in a gene trap approach performed in mouse embryonic stem cells, 
the ZFPIP/Zfp462 gene has been disrupted and the resulting mice either died or presented 
growth deficiency. However, in this work, the gene trap procedure had introduced an insertion 
that caused the expression of a dominant negative form of the protein but not the loss of 
function of the gene (Skarnes et al., 1992). Unfortunately, no further experiment has been 
performed by these authors or by others that could highlight the developmental role of the 
gene in mammalians. Therefore, generation of knock-out mice for ZFPIP/Zfp462 would be a 
useful tool to study the role of the gene during mammal’s development. 
  
 
Knock-down expression of ZFPIP impairs cell division and triggers cell death  
  
 Using an amphibian model, we showed that the knock-down of ZFPIP/Zfp462 
triggered severe abnormal phenotype demonstrating that the gene was essential for 
embryogenesis. Since the effects of the knock-down of the protein appear to be very drastic, 
we first tested the expression of some markers of germ layers specification. By analysing the 
expression of early markers of mesoderm (Xbra), neuroderm (Sox2) and endoderm (Sox17α), 
we did not observe any significant differences in morphant and control embryos, suggesting 
that germ layer specification was correctly induced (figure 5A). In order to further understand 
the involvement of the gene in development, we tried to determine the earliest stage at which 
abnormal phenotype was visualized. In fact, cells presenting a bigger size than normal 
blastomeres were observed in xZFPIP MOs injected embryos, as soon as stage 5 (figure 5B). 
This phenotype was directly observable but was also visible after confocal microscopy 
analysis performed on stage 12 embryos (figure 5B). These first data suggested an impairment 
of cell division. Indeed, using DAPI staining, we observed several aberrant mitosis or 
interphases in xZFPIP MOs injected embryos. As shown in figure 5C, several cells exhibited 
none, bigger or micro nuclei. In addition, mitotic cells underwent atypical mitosis, showing 
aberrant metaphase, anaphase, incomplete chromosome segregation, conjoined nuclei (figure 
5C). Amongst these abnormal cell phenotypes observed in morphant embryos, cells exhibiting 
none or abnormal nuclei (with conjoined chromatin or nuclei) were particularly abundant 
(30%, n=50). Such altered mechanisms inevitably induce cell death and are thus deleterious 
for embryos.  
 To study the impact of ZFPIP MOs on cell division and/or cell death in the xenopus 
embryo, we performed two complementary analyses. Firstly, using the mitotic marker 
Phospho histone H3 (PH3), we evaluated the division rate of embryo cells and observed a 
striking decrease of cell mitosis in ZFPIP/Zfp462 depleted cells (90% of the animal cap 
explants exhibited no more PH3 immunostaining, n=11) (figure 6A). Secondly, we showed 
that xZFPIP MO1 injected cells did not significantly exhibit cell death earlier than in control 
until stage 20, as demonstrated by TUNEL assay (figure 6B). The results thus demonstrated 
that the knock-down of ZFPIP/Zfp462 in embryos impaired cell cycle and induced later on 
cell death. Indeed, these data could be interpreted by a mechanism of cell death, known as 
mitotic catastrophe, which is an event occurring after microtubules inhibition or DNA 
damage. In this mechanism, DNA damage can arrest cells in G1/G2, transcription is inhibited 
and subsequently, cells die by secondary apoptosis (Blagosklonny, 2007).  
 Further experiments will be necessary to precise the molecular mechanisms triggered 
by ZFPIP/Zfp462 during early embryogenesis. However, the available data obtained so far in 
our laboratory indicated that the protein could play a role in chromatin conformation. Indeed, 
the protein was found in the germinal vesicle of oocyte (data not shown) and remained 
nuclear in the blastomeres of xenopus embryo during the early stages of its development. In 
addition, embryonic cells in which the knock-down of the gene has been performed, exhibited 
a relaxed chromatin compared to control cells (Masse et al., in preparation). In order to better 
understand the function of ZFPIP/Zfp462, additional experiments will be performed using the 
model of embryonic cell in culture, which is a more convenient model to investigate 
molecular and cellular mechanisms. Indeed, xenopus cells contain high amount of vitellus 
which makes difficult the analysis of markers by microscopy approaches. 
 The overall data on ZFPIP/Zfp462 reveal that this newly identified gene has an 
instrumental role during vertebrate development. Playing a role in cell division, this large 
protein containing numerous zinc fingers might act on chromatin structure and therefore be 
determinant in the control of genetic programs during vertebrate development.  
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Figure legends 
 
Fig. 1. ZFPIP is a highly conserved zinc finger protein. ZFPIP is a 250 kDa protein that 
contains 26 conserved C2H2 motifs and one NLS (A). Amino acid sequence is conserved 
from Danio rerio to Mus musculus; Mn: Mus musculus; Rn: Ratus norvegicus; Hs: Homo 
sapiens; Cf: Canis familiaris; Bt: Bovis Taurus; Gg: Gallus gallus; Tn: Tetraodon nigroviridis 
(B). Sequences available in amphibian models and conservation between Xenopus laevis (Xl) 
and Xenopus tropicalis (Xt). Overlapping sequences of cDNAs between the two species were 
compared and were determined to be at least 94% homologous (C). 
 
Fig. 2. ZFPIP is maternally and zygotically expressed during Xenopus laevis development. 
RT-PCR experiments using Xenopus laevis embryo RNA extracts show that ZFPIP mRNAs 
are present in stage 1 and then decrease until stage 12. Transcription of mRNAs is enhanced 
at stage 17 (A). The ZFPIP protein is maternally present in oocytes. The amount of protein is 
then diluted during the cleavage phase. The α–PCNA antibody is used as an internal 
quantitative control (B). Whole mount immunohistochemistry assays are performed on 
Xenopus laevis embryos using an α–ZFPIP or preimmune serum at stages 5, 8, 20 and 39. 
The pictures show that ZFPIP is mostly present in the animal pole of blastula and 
progressively localises in developing neural tissues (C). Western blots confirm that the protein 
is preferentially localised in the animal pole. AP, VP and E correspond respectively to animal 
pole, vegetal pole and embryo protein extracts (D). Nuclear localization of endogenous ZFPIP 
or hZFPIP-FLAG protein is observed in embryos or in hZFPIP mRNA injected embryos. The 
immunohistochemistry is performed with α–ZFPIP or α–FLAG antibodies on Xenopus laevis 
embryos explants (stage 20) (E).  
 
Fig. 3. ZFPIP depletion impairs xenopus development. Stage VI oocytes are incubated either 
in 10 µg/mL cycloheximide or in a cycloheximide-free culture medium. Total protein extracts 
of oocytes collected after different times of incubation are analyzed by Western blotting using 
an α–ZFPIP serum and α–PCNA antibody (A). Stage VI oocytes are injected with 50 ng of 
ctrl MO or xZFPIP MO1 and allowed to develop for different times. Western blots of total 
protein extracts of oocytes are analyzed using an α–ZFPIP serum and α–PCNA antibodies; 
they demonstrate the specificity of the xZFPIP MO1 (B). Embryos are injected in one 
blastomere at the two-cell stage with 50 ng of ctrl MO (D, H, L, P) or 25-50 ng of xZFPIP 
MO1 (A-C, E-G, I-K, M-O) and are allowed to develop (C). Embryos are injected with 50 ng 
of xZFPIP MO1 and 1ng of GFP mRNA. They grow until stage 12 and are observed using a 
fluorescence binocular (D). Embryos are either injected with 25-50 ng of ctrl MO, ctrl MO1, 
xZFPIP MO1, xZFPIP MO2 or not injected and allowed to develop until stage 8. Depletion of 
ZFPIP protein is demonstrated by Western blot performed with total protein extracts and 
analyzed using an α-ZFPIP serum and α–PCNA antibody. Depletion of ZFPIP by MO1 has 
been performed by injecting one blastomere at the 2 cell-stage and depletion of ZFPIP by 
MO2 has been performed by injecting the 2 blastomeres at the same developmental stage (E). 
 
Fig. 4. hZFPIP mRNA rescues the gastrulation defect observed in embryos injected with 
xZFPIP MO. Xenopus laevis embryos are injected with either 50 ng of ctrl MO, 1-5 ng of 
hZFPIP RNA, 25 ng of xZFPIP MO1 or 25 ng of xZFPIP M1 and 1-5 ng of hZFPIP RNA. 
The percentage of normal embryos obtained after the different injections are given in the table 
and are represented by histograms.  
 
Fig. 5. xZFPIP knock-down does not alter germ layer specification but impairs cell divisions 
in Xenopus laevis embryos. RT-PCR experiments demonstrate that Xbra, Sox2 and Sox17α 
are correctly induced in morphant embryos at stage 7, 10 and 12.5. RNAs are extracted from 
xZFPIP MO1 injected embryos (Mo) or ctrl MO injected (Ct). Enzymatic reactions are 
performed with (RT+) or without (RT-) reverse transcriptase. Standard PCR protocol is used 
with the primers indicated in methods (A). Stage 5 Xenopus laevis morphant shows aberrant 
cell size and shape (B, b1). Stage 12 Xenopus laevis explants stained with DAPI (nuclei 
staining) and phalloïdine-Fluoroprobe 547H (F-actin staining) exhibit bigger cells containing 
altered DNA content (B, b2). Scale bar represents 100µm (B). DAPI stained animal caps of 
morphant embryos contain cells with variable nucleus shape (C, c1-3), conjoined chromatin 
or nuclei (C, c1-2), micronuclei (C, c3), tripolar metaphases and anaphases (C, c4-6) or 
anuclear cells (C,c2). 
 
Fig. 6. xZFPIP knock-down prevents cell mitosis and triggers cell death in Xenopus laevis 
embryos. Xenopus laevis embryos are injected in one blastomere at the two-cell stage with 
25-50 ng of xZFPIP MO1 or ctrl MO. Embryos are then allowed to develop until stage 12. 
Animal cap explants are prepared, immunostained using an α-PH3 antibody and nuclei 
stained with DAPI (A). Xenopus laevis embryos are injected in one blastomere at the two-cell 
stage with 25-50 ng of xZFPIP MO or ctrl MO and are allowed to develop until stage 20-22. 
The TUNEL assay performed on whole (a, b) or sectioned embryos (c, d) shows a staining in 
the presumptive neural region (arrows). 
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